Biosynth Carbosynth Expands Peptide Offering with Acquisition of Pepscan

Addition of Pepscan with its peptide discovery, lead optimization and GMP manufacturing capabilities provides end-to-end offering to Biosynth Carbosynth’s peptide customers. 

Staad, 30 June 2022 – Biosynth Carbosynth (“Biosynth”), a supplier of critical products and services to the life sciences industry, announces today the acquisition of Pepscan, an expert provider of peptide-based products & services.

Biosynth’s ability to deliver chemical manufacturing services “from the first idea to the finished product” is now matched in peptides, with Pepscan’s expertise in both lead discovery & optimization and GMP production combining with the capabilities of vivitide, the US peptide specialists, which joined Biosynth in March.

The two companies will form Biosynth’s new Peptide division, with broad capabilities and offering to the pharma & biotech, diagnostics and cosmetics industries, and their academic counterparts. Pepscan also brings proprietary technologies, like its patented CLIPS™ technology, which locks peptides into active conformations. CLIPS peptides are applied for lead discovery and optimization, as well as in its epitope mapping platform.

Dr. Urs Spitz, CEO and President of Biosynth, said, “We are thrilled to be able to bring Pepscan’s outstanding peptide expertise into the group and form our new, global Peptide division. This allows us to continue to simplify the supply chains for our customers across life sciences, pharma and diagnostics, so they deal with one organization for all of their needs. Pepscan is known for their scientific knowledge and expertise and have a complementary set of manufacturing to those we have already, including GMP capabilities, so it was a perfect fit”.

Hans de Backer, CEO of Pepscan, said, “This is a fantastic time to be joining Biosynth and expanding their platform in peptides.” He went on: “Pepscan has just celebrated 25 years of our leading role at the forefront of peptide developments. We are excited to look to the future with Biosynth’s global footprint enabling us to serve more customers. The entire Biosynth peptide operation can deliver a more extensive set of products & services to global customers across research, development and commercial supply”.

Read more about Biosynth Carbosynth on or reach out to

We use cookies to ensure that we give you the best experience on our website. If you would like to, you can change your cookie settings in your browser.
For more information check our privacy policy
Find out more
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Cookie Settings
Accept All Cookies